Prognostic Enrichment is a strategy of enriching a clinical trial for testing an intervention intended to prevent or delay an unwanted clinical event. A prognostically enriched trial enrolls only patients who are more likely to experience the unwanted clinical event than the broader patient population (R. Temple (2010) <doi:10.1038/clpt.2010.233>). By testing the intervention in an enriched study population, the trial may be adequately powered with a smaller sample size, which can have both practical and ethical advantages. This package provides tools to evaluate biomarkers for prognostic enrichment of clinical trials with survival/time-to-event outcomes.
Version: | 0.1.0 |
Depends: | R (≥ 3.1.0) |
Imports: | survival, ggplot2, gridExtra |
Published: | 2020-01-12 |
Author: | Si Cheng [cre, aut], Kathleen F. Kerr [ctb] |
Maintainer: | Si Cheng <chengsi at uw.edu> |
License: | GPL-2 | GPL-3 [expanded from: GPL (≥ 2)] |
NeedsCompilation: | no |
CRAN checks: | BioPETsurv results |
Reference manual: | BioPETsurv.pdf |
Package source: | BioPETsurv_0.1.0.tar.gz |
Windows binaries: | r-devel: BioPETsurv_0.1.0.zip, r-release: BioPETsurv_0.1.0.zip, r-oldrel: BioPETsurv_0.1.0.zip |
macOS binaries: | r-release: BioPETsurv_0.1.0.tgz, r-oldrel: BioPETsurv_0.1.0.tgz |
Please use the canonical form https://CRAN.R-project.org/package=BioPETsurv to link to this page.